BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 19629022)

  • 21. In vitro evaluation of the interaction potential of irosustat with drug-metabolizing enzymes.
    Ventura V; Solà J; Peraire C; Brée F; Obach R
    Drug Metab Dispos; 2012 Jul; 40(7):1268-78. PubMed ID: 22451700
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of inhibitory effects of caffeic acid and quercetin on human liver cytochrome p450 activities.
    Rastogi H; Jana S
    Phytother Res; 2014 Dec; 28(12):1873-8. PubMed ID: 25196644
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro inhibition and induction of human hepatic cytochrome P450 enzymes by modafinil.
    Robertson P; DeCory HH; Madan A; Parkinson A
    Drug Metab Dispos; 2000 Jun; 28(6):664-71. PubMed ID: 10820139
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibitory effects of cytostatically active 6-aminobenzo[c]phenanthridines on cytochrome P450 enzymes in human hepatic microsomes.
    Zebothsen I; Kunze T; Clement B
    Basic Clin Pharmacol Toxicol; 2006 Jul; 99(1):37-43. PubMed ID: 16867169
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibitory Effects of Dimethyllirioresinol, Epimagnolin A, Eudesmin, Fargesin, and Magnolin on Cytochrome P450 Enzyme Activities in Human Liver Microsomes.
    Kim JH; Kwon SS; Jeong HU; Lee HS
    Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28468305
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of Naltrexone Hydrochloride on Cytochrome P450 1A2, 2C9, 2D6, and 3A4 Activity in Human Liver Microsomes.
    AlRabiah H; Ahad A; Mostafa GAE; Al-Jenoobi FI
    Eur J Drug Metab Pharmacokinet; 2018 Dec; 43(6):707-713. PubMed ID: 29744741
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug interaction potential of toremifene and N-desmethyltoremifene with multiple cytochrome P450 isoforms.
    Kim J; Peraire C; Solà J; Johanning KM; Dalton JT; Veverka KA
    Xenobiotica; 2011 Oct; 41(10):851-62. PubMed ID: 21726172
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro effects of natural prenyloxycinnamic acids on human cytochrome P450 isozyme activity and expression.
    Genovese S; Epifano F; Curini M; Menger D; Zembruski NC; Weiss J
    Phytomedicine; 2011 May; 18(7):586-91. PubMed ID: 21112752
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of cytochrome P450 by ethambutol in human liver microsomes.
    Lee SY; Jang H; Lee JY; Kwon KI; Oh SJ; Kim SK
    Toxicol Lett; 2014 Aug; 229(1):33-40. PubMed ID: 24910189
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro evaluation of the inhibition and induction potential of olaparib, a potent poly(ADP-ribose) polymerase inhibitor, on cytochrome P450.
    McCormick A; Swaisland H; Reddy VP; Learoyd M; Scarfe G
    Xenobiotica; 2018 Jun; 48(6):555-564. PubMed ID: 28657402
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro inhibition and induction of human cytochrome P450 enzymes by mirabegron, a potent and selective β3-adrenoceptor agonist.
    Takusagawa S; Miyashita A; Iwatsubo T; Usui T
    Xenobiotica; 2012 Dec; 42(12):1187-96. PubMed ID: 22834478
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification and characterization of potent CYP2D6 inhibitors in lotus leaves.
    Ye LH; He XX; Kong LT; Liao YH; Pan RL; Xiao BX; Liu XM; Chang Q
    J Ethnopharmacol; 2014 Apr; 153(1):190-6. PubMed ID: 24561383
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetic interaction profile of riociguat, a new soluble guanylate cyclase stimulator, in vitro.
    Rickert V; Haefeli WE; Weiss J
    Pulm Pharmacol Ther; 2014 Aug; 28(2):130-7. PubMed ID: 24657506
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of human cytochromes P450 in vitro by ritonavir and cobicistat.
    Hossain MA; Tran T; Chen T; Mikus G; Greenblatt DJ
    J Pharm Pharmacol; 2017 Dec; 69(12):1786-1793. PubMed ID: 28960344
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of lycopene on cytochrome P450 isoenzymes and P-glycoprotein by using human liver microsomes and Caco-2 cell monolayer model.
    Kong L; Song C; Ye L; Xu J; Guo D; Shi Q
    Int J Food Sci Nutr; 2018 Nov; 69(7):835-841. PubMed ID: 29322841
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibiton of cytochrome P450 isoenzymes and P-gp activity by multiple extracts of Huang-Lian-Jie-Du decoction.
    Wang Y; Jiang YM; Wang YT; Kang JW; Yu T; Zhao HY; Bian BL; Huang M; Bi HC
    J Ethnopharmacol; 2014 Oct; 156():175-81. PubMed ID: 25219605
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibitory effects of limonin on six human cytochrome P450 enzymes and P-glycoprotein in vitro.
    Han YL; Yu HL; Li D; Meng XL; Zhou ZY; Yu Q; Zhang XY; Wang FJ; Guo C
    Toxicol In Vitro; 2011 Dec; 25(8):1828-33. PubMed ID: 22001672
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An Assessment of the In Vitro Inhibition of Cytochrome P450 Enzymes, UDP-Glucuronosyltransferases, and Transporters by Phosphodiester- or Phosphorothioate-Linked Oligonucleotides.
    Kazmi F; Yerino P; McCoy C; Parkinson A; Buckley DB; Ogilvie BW
    Drug Metab Dispos; 2018 Aug; 46(8):1066-1074. PubMed ID: 29735754
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An evaluation of the cytochrome p450 inhibition potential of lisdexamfetamine in human liver microsomes.
    Krishnan S; Moncrief S
    Drug Metab Dispos; 2007 Jan; 35(1):180-4. PubMed ID: 17035599
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibitory effects of cytochrome P450 enzymes CYP2C8, CYP2C9, CYP2C19 and CYP3A4 by Labisia pumila extracts.
    Pan Y; Tiong KH; Abd-Rashid BA; Ismail Z; Ismail R; Mak JW; Ong CE
    J Ethnopharmacol; 2012 Sep; 143(2):586-91. PubMed ID: 22885070
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.